Vitality Watch

Dossier pubmed preclinical 01-nov-2026
Animal model, organoid, or cell-culture result — not yet human

The AIM2 inflammasome drives age-dependent cardiac dysfunction following ischemia-reperfusion in mice.

Key claim: Age-dependent induction of the AIM2 inflammasome primes a pro-inflammatory cardiac microenvironment that exacerbates post-ischemia-reperfusion dysfunction in aged mice.

Abstract

Cardiac aging increases susceptibility to cardiovascular diseases (CVDs), particularly myocardial infarction. Although evidence suggest an association between activation of the absent in melanoma 2 (AIM2) inflammasome and CVDs, its contribution to age-related cardiac complications remains unknown. We investigated the role of the AIM2 inflammasome and the cardiac response to ischemia-reperfusion (I/R) injury in aged mice. Male wildtype (C57BL/6) and AIM2-deficient (AIM2-/-) mice were subjected to natural aging (21 months), using 3-month-old mice as controls, and human cardiomyocytes (AC16) were stressed by hydrogen peroxide to mimic senescent. AIM2 expression was up-regulated in the aged myocardium and senescence AC16 cells, coinciding with increased levels of cleaved caspase-1 (p20), IL-1β, and IL-18. Functional assays in Langendorff-perfused hearts revealed that AIM2 deficiency significantly attenuated post-I/R dysfunction in aged mice, restoring left ventricular developed pressure (LVDP) and pressure derivatives (+dP/dTmax and -dP/dTmin) toward pre-ischemic levels. While AIM2 absence did not alter age-associated hypertrophy, fibrosis, longevity, or senescence markers (p53 and p21), it reduced the baseline pro-inflammatory and pro-pyroptotic profile of the aged heart (IL-1β, IL-18, GSDMD-N, and ASC speck). In vitro, AIM2 activation using Poly(dA:dT) elevated IL-1β, GSDMD-N, ASC speck, and cell death in senescent cells, whereas pharmacological inhibition with A151 prevented these effects. Concurrently, age-dependent AIM2 up-regulation was confirmed in human cardiac datasets. Together, these findings suggest that age-dependent AIM2 induction primes a pro-inflammatory cardiac microenvironment, exacerbating post-I/R injury and highlighting this pathway for future investigation in the context of cardiac aging.

Why this matters

The mouse findings [animal-model] identify AIM2 as a specific contributor to the aged heart’s vulnerability to ischemia-reperfusion and distinguish this inflammatory injury pathway from explanations centered on classic senescence markers. Age-associated AIM2 upregulation in human cardiac data [human-observational] supports a human expression parallel, but does not establish that AIM2 drives human cardiac injury or that targeting it improves recovery.

Source

Link

Briefing card

The AIM2 inflammasome drives age-dependent cardiac dysfunction following ischemia-reperfusion in mice.
Stage: preclinical · pubmed · 01-nov-2026

Age-dependent induction of the AIM2 inflammasome primes a pro-inflammatory cardiac microenvironment that exacerbates post-ischemia-reperfusion dysfunction in aged mice.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1042/CS20260997

build build 880 · 2bcef25 · 2026-11-18